1-50418939-G-A
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_032110.3(DMRTA2):c.1355C>T(p.Ala452Val) variant causes a missense change. The variant allele was found at a frequency of 0.0000709 in 1,439,474 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000072 ( 0 hom., cov: 34)
Exomes 𝑓: 0.000071 ( 0 hom. )
Consequence
DMRTA2
NM_032110.3 missense
NM_032110.3 missense
Scores
2
3
14
Clinical Significance
Conservation
PhyloP100: 5.68
Genes affected
DMRTA2 (HGNC:13908): (DMRT like family A2) Enables sequence-specific double-stranded DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II and sex differentiation. Predicted to act upstream of or within nervous system development and skeletal muscle cell differentiation. Predicted to be part of chromatin. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 0 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.23735765).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DMRTA2 | NM_032110.3 | c.1355C>T | p.Ala452Val | missense_variant | 3/3 | ENST00000404795.4 | NP_115486.1 | |
DMRTA2 | XM_011541937.3 | c.1355C>T | p.Ala452Val | missense_variant | 2/2 | XP_011540239.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DMRTA2 | ENST00000404795.4 | c.1355C>T | p.Ala452Val | missense_variant | 3/3 | 5 | NM_032110.3 | ENSP00000383909.3 | ||
DMRTA2 | ENST00000418121.5 | c.1355C>T | p.Ala452Val | missense_variant | 2/2 | 1 | ENSP00000399370.1 |
Frequencies
GnomAD3 genomes AF: 0.0000724 AC: 11AN: 151998Hom.: 0 Cov.: 34
GnomAD3 genomes
AF:
AC:
11
AN:
151998
Hom.:
Cov.:
34
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000414 AC: 2AN: 48302Hom.: 0 AF XY: 0.0000698 AC XY: 2AN XY: 28642
GnomAD3 exomes
AF:
AC:
2
AN:
48302
Hom.:
AF XY:
AC XY:
2
AN XY:
28642
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000707 AC: 91AN: 1287476Hom.: 0 Cov.: 29 AF XY: 0.0000789 AC XY: 50AN XY: 633494
GnomAD4 exome
AF:
AC:
91
AN:
1287476
Hom.:
Cov.:
29
AF XY:
AC XY:
50
AN XY:
633494
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000724 AC: 11AN: 151998Hom.: 0 Cov.: 34 AF XY: 0.0000674 AC XY: 5AN XY: 74236
GnomAD4 genome
AF:
AC:
11
AN:
151998
Hom.:
Cov.:
34
AF XY:
AC XY:
5
AN XY:
74236
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
TwinsUK
AF:
AC:
1
ALSPAC
AF:
AC:
3
ExAC
AF:
AC:
1
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 15, 2023 | The c.1355C>T (p.A452V) alteration is located in exon 3 (coding exon 2) of the DMRTA2 gene. This alteration results from a C to T substitution at nucleotide position 1355, causing the alanine (A) at amino acid position 452 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
T;T
Eigen
Uncertain
Eigen_PC
Benign
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
.;D
M_CAP
Benign
D
MetaRNN
Benign
T;T
MetaSVM
Benign
T
MutationAssessor
Benign
L;L
PrimateAI
Pathogenic
D
PROVEAN
Benign
N;N
REVEL
Benign
Sift
Benign
T;T
Sift4G
Benign
T;T
Polyphen
D;D
Vest4
MutPred
Loss of disorder (P = 0.0532);Loss of disorder (P = 0.0532);
MVP
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at